Interactions of serotonin reuptake inhibitors with tricyclic antidepressants.
Harvey
A T
AT
Preskorn
S H
SH
D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000494:pharmacology*; D019389:Cytochrome P-450 CYP2D6; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000097:blood / Q000235:genetics; D004347:Drug Interactions; D006801:Humans; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors / Q000097:blood / Q000235:genetics; D009251:NADPH-Ferrihemoprotein Reductase; D010088:Oxidoreductases / Q000187:drug effects / Q000378:metabolism; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000494:pharmacology*; D015262:Xenobiotics / Q000378:metabolism
D000929:Antidepressive Agents, Tricyclic; D019389:Cytochrome P-450 CYP2D6; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; D009251:NADPH-Ferrihemoprotein Reductase; D010088:Oxidoreductases; D017367:Selective Serotonin Reuptake Inhibitors; D015262:Xenobiotics